QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

	Help viewing high resolution images
	Return to article

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. In vitro characterization of soluble human VEGFR-3 and mAb hF4-hF4-3C5. (A) Conditioned media from cells expressing human sR3-AP ( ${circ}$ ), human sR2-AP ( ${blacksquare}$ ) or human sR1-AP ( ${square}$ ) were normalized for AP activity and added to 96-well plates coated with VEGF-C_NC. Bound receptors were detected with a rabbit antibody to AP and peroxidase-labeled secondary antibodies. sR3-AP binds to VEGF-C_NC with an EC₅₀ about ten times lower than sR2-AP whereas sR1-AP does not show binding activity. (B) Conditioned media were normalized for AP activity and added to 96-well plates coated with either VEGF-C_NC or VEGF-A. The amount of bound receptor was measured using AP activity. R3-AP (clear bars) binds strongly to VEGF-C_NC but not to VEGF-A. Control media from cells expressing untagged AP shows no binding (black bars). (C) Purified sR3-AP (µ), sR2-AP ( ${circ}$ ) or sR1-AP ( ${blacksquare}$ ) were added to 96-well plates coated with hF4-3C5. The amount of bound receptor was measured using AP activity. sR3-AP binds to the mAb hF4-3C5 whereas sR1-AP or sR2-AP show no detectable binding. (D) Inhibition of sR3-AP binding to VEGF-C_NC by the mAb hF4-3C5. Saturating amounts of sR3-AP were mixed with various amounts of mAbs or Fab fragments and added to 96-well plates coated with VEGF-C_NC. Blocking of the receptor binding is evident with full-length hF4-3C5 ( ${triangleup}$ , IC₅₀=1.3 nM), and Fab fragments of hF4-3C5 ( ${square}$ , IC₅₀=2 nM) but not with the irrelevant human mAb IMC-2F8 ( ${circ}$ ).

Return to article